A phase Ib, open label, dose escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia

Alexey Danilov, Stephen E. Spurgeon, Tanya Siddiqi, Anne Marie Quinson, Daniela Maier, Dionne Smith, Jennifer R. Brown

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'A phase Ib, open label, dose escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences